PDA Capital Area Chapter at American Gene Technologies

Rebecca Stauffer, Parenteral Drug Association Managing Editor posed the following questions to PDA Letter Article readers in fall of 2019. "What if developers of cell and gene therapies treated their products like software releases? What if the human body could be manipulated like a highly complex computer?"

We invite you to join us for a LIVE and energetic presentation from Jeff Galvin, CEO of American Gene Technologies sharing his passion, vision, and conviction of "reprogramming the human computer."

This is the story of how an individual was motivated to act upon influences of the Silicon Valley Tech industry to then inspire creative development in Biotech.

Jeff will walk us through how his company leverages viral vector technology to provide therapies for HIV and a multitude of diseases.

Maybe you'll draw up your own conclusions and inspiration? Take part to find out.

Key Takeaways

• Insight of how biotech should be inspired by Silicon Valley
• Understanding the challenges of cell and gene therapy manufacturing and the scale-up process
• Realization of how a viral vector platform could be licensed to other pharma companies

Who Should Attend?

Anyone who is excited about the possibilities of Advanced Cell and Gene Therapy is welcome to attend.

Quality, Manufacturing, Process, Engineering, Researchers and Scientists, Early-Phase Development, Clinical Manufacturing, Operations, and Technology.

Sponsorship opportunities are available:

We have two opportunities for sponsorship with our chapter. We offer vendors, consultants, operating companies and other organizations the opportunity to promote themselves and also support the PDA Capital Area Chapter by purchasing one of these selections.

Opportunities close March 1, 2020.

• Annual Sponsor
• Event Sponsor